+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 1
Age: 18Years - 50Years
All Genders
Healthy Volunteers
ID07758972

Phase 1 Randomized Trial Testing Safety and Immune Response of a Multivalent Neisseria Gonorrhoeae Vaccine in Healthy Adults

Led by LimmaTech Biologics AG · Updated on 2026-09-23

142

Participants Needed

1

Research Sites

21 weeks

Total Duration

AI-Summary

What This Trial Is About

This research aims to evaluate the safety and immune response of a new vaccine candidate called LTB-NG6, designed to prevent Neisseria gonorrhoeae infection. The study focuses on healthy adults aged 18 to 50 years and is a phase 1 trial to assess initial safety and immune reactions. Participants are randomly assigned to receive either one of five different doses of the vaccine or a placebo. Participants will receive two doses of either the investigational vaccine at varying dose levels or a placebo consisting of sodium chloride 0.9%. The vaccine includes six different Neisseria gonorrhoeae antigens and is administered in a two-dose schedule. The study is conducted using a double-blind design, meaning neither participants nor researchers know who receives which treatment during the trial. During the study, participants will be monitored for local and systemic adverse events for seven days after each injection and for any other events for 28 days post-injection. Unsolicited adverse events will be followed throughout the study, which lasts around 18 months on average. Immune responses will be measured by antibody levels 28 days after the second injection, with additional examinations of safety and lab tests at baseline and after each dose. Participants will also complete diary forms and attend follow-up visits and phone calls throughout the trial.

CONDITIONS

Brief Title

Safety and Immunogenicity Study of a Multivalent Gonorrhoea Vaccine

Research Team

S

Steffen Haffner, Dr.

C

Christian Reh, Dr.

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here